FDA-approved
Immune & defense
Cyclosporine
Evidence
FDA approved
Class
Cyclic peptide immunosuppressant
KEY TAKEAWAY
Cyclosporine is a cyclic peptide of 11 amino acids made by a soil fungus. It is sold as Sandimmune, Neoral and Gengraf, and as eye drops (Restasis). The FDA approved cyclosporine in 1983 to prevent rejection after organ transplants. Other forms are approved for psoriasis, rheumatoid arthritis and dry eye disease.
Written by the Veylo editorial team · Updated
November 2026
What it is
Cyclic peptide immunosuppressant
Approved for
Preventing organ transplant rejection and treating some autoimmune conditions
Key fact
The FDA approved cyclosporine in 1983 to prevent rejection after organ transplants. Other forms are approved for psoriasis, rheumatoid arthritis and dry eye disease.
Route
Oral, intravenous or eye drops depending on the product
Evidence strength
FDA approved
Cyclosporine is a cyclic peptide of 11 amino acids made by a soil fungus. It is sold as Sandimmune, Neoral and Gengraf, and as eye drops (Restasis).
It blocks calcineurin in T cells, which prevents them from sending the signals that drive immune attacks.
The FDA approved cyclosporine in 1983 to prevent rejection after organ transplants. Other forms are approved for psoriasis, rheumatoid arthritis and dry eye disease.
Preventing organ transplant rejection and treating some autoimmune conditions.
Kidney damage, high blood pressure and a higher risk of infections and some cancers are the main concerns, so blood levels are monitored.
U.S. FDA prescribing information for Cyclosporine. DailyMed, National Library of Medicine.
Veylo content is educational and not medical advice. Peptides that are not FDA-approved are not approved for the uses described.